Fig. 1From: A nomogram based on platelet-to-lymphocyte ratio for predicting pathological complete response of breast cancer after neoadjuvant chemotherapyThe difference of PLR before NAC in pCR and Non-pCR patients with breast cancer. PLR: Platelet-to-lymphocyte ratio; NAC: Neoadjuvant chemotherapy; pCR: Pathological complete responseBack to article page